Elevance falls as 2026 profit forecast drops below expectations

Shares of U.S. health insurer Elevance ELV.N decline 6.7% to $301 in premarket trading

ELV forecasts FY 2026 adj. profit to be at least $25.50 per share, below analysts' average estimate of $26.90, according to data compiled by LSEG

Reports Q4 adj. profit of $3.33 per share, beating analysts' average estimate of $3.10

Posts Q4 revenue of $49.3 billion, vs. estimates of $49.82 billion

Also reports a quarterly medical loss ratio of 93.5%, compared with estimates of 93.39%

ELV stock fell nearly 5% in 2025